Your Search Returned 60 tagged news reports
Kazakhstan government for $4.6bn (3.4bn) after a choppy period as a public company. The mining company, which was set up by three Kazakh oligarchs, was once described by a former director as being "more soviet than city". July 2012 as it attempted to
ROB Insight access is exclusively available to Globe Unlimited subscribers ROB Insight is The Globe and Mail's exclusive feature led by a team of award-winning editors and writers who provide you with in-depth analysis on breaking business news and
Published in Company Comment on 15 March 2013 Rentokil Initial plc (LON: RTO) reveals annual profits up 4% and a strong fourth quarter...Rentokil announced a 2.1p per share payout for 2012, which compared with a 1.33p per share dividend declared this
Suggested Topics Pest control group Rentokil Initial is facing fresh concerns over the future of its facilities business, adding to longstanding issues at its troubled parcel delivery arm. Sources within its facilities management operation, which
News out of Las Vegas doesn't usually rock the benchmark index in London, but its annual Consumer Electronics Show this week has been perking up Arm Holdings' share price, it would seem. The microchip designer was top of the tree and its share price
What you need to know about the utility company's top executives. Management can make all the difference to a company's success and thus its share price. The best companies are those run by talented and experienced leaders with strong vested
Western Exterminator Co., the family-owned Anaheim firm known for its trademark logo of the little man with a big hammer towering over a mouse, has been sold to British-based Rentokil Initial plc for up to $114.6 million. Rentokil said the
News in pictures Rentokil Initial is taking the fight to the rats and other vermin of the US by acquiring a pest control company on its west coast for more than $100m (£61m). The business services specialist is to acquire Western Exterminator Company
Suggested Topics Punters in Allergy Therapeutics were breathing a little bit easier yesterday. The Aim-listed drugs company was enjoying a revival after regulators in the States finally decided to rescue its grass pollen allergy vaccine from limbo.
Satellite operator Inmarsat said it had returned its core maritime business to growth, thanks to increased subscriber numbers and price changes. With revenues edging up $1m to $684m in the first half, the company's shares have climbed 41.7p to 526p.